ANDA 88560, held by Actavis Elizabeth. Hydralazine Hydrochloride.
As of Nov 15, 2026, ANDA 88560 (Hydralazine Hydrochloride), held by Actavis Elizabeth, was not approved, with 0 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Hydralazine Hydrochloride25MG ยท tablet;oral | Hydralazine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
